Twist Bioscience’s Dr. Emily LeProust Disrupting the Future of Bioscience May 19, 2021 Female entrepreneurs are disrupting the traditionally male-dominated field of bioscience. One such disruptor is Dr. Emily Leproust, CEO and co-founder of Twist Bioscience (TWST), whose pioneering work on DNA-based applications and high-throughput DNA synthesis and sequencing is being used in everything from the fight against COVID-19 to brewing a better bottle of beer. “High-throughput DNA sequencing” refers to a range of next-gen technologies that, essentially, make DNA synthesis and gene sequencing much quicker and more inexpensive to carry out. That in turn enables genetic engineering to be used in a range of medical and non-medical applications that before would have been cost-prohibitive, including digital data storage, medical diagnostics, therapeutics, food technology, and more.